Acquisition Announced

Gilead acquisition of Ouro Medicines

US$1.7bn consideration

Announced 24 Mar 2026

Advisers

Target
Ouro Medicines
Acquirer
Gilead
Target based in
United States
Buyer based in
United States
Sector
Biotech
Tags
Biotech, Drug Development

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.